Manabu Sotomatsu

Shibukawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.

TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.

Journal: Genes, chromosomes & cancer

Published: January 17, 2023

UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.

UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.

Journal: Genes, chromosomes & cancer

Published: June 10, 2022

Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.

Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.

Journal: Blood advances

Published: May 27, 2021

Therapeutic options for CTLA-4 insufficiency.

Therapeutic options for CTLA-4 insufficiency.

Journal: The Journal of allergy and clinical immunology

Published: November 19, 2020

Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution.

Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution.

Journal: International journal of hematology

Published: September 01, 2020

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.

Journal: Haematologica

Published: August 28, 2020

Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup.

Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup.

Journal: British journal of haematology

Published: May 08, 2019

Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Journal: Blood advances

Published: May 07, 2019

Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.

Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.

Journal: International journal of hematology

Published: April 13, 2019

Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.

Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.

Journal: International journal of hematology

Published: November 02, 2018

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Journal: International journal of hematology

Published: November 16, 2017

RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.

RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.

Journal: Blood

Published: November 02, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026